An interventional study of Short Burst Interval Treadmill Training (SBLTT) and Traditional Locomotor Treadmill Training (TLTT) in Cerebral Palsy, sponsored by Kristie Bjornson. Completed at 2 sites in United States. Open to participants aged 6 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Kristie Bjornson · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.
Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 60th largest by enrollment of the 296 interventional ones that give a count, is one of 20 that started in 2019, is one of 218 with no phase, and was the 190th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:
University of Washington · Sites in United States
Ages 4–65
University of Wisconsin, Madison · Sites in United States
Ages 7–17
Columbia University · Sites in United States
Ages 18–80
Martin Piazza · Sites in United States
Ages 3–14
National Institutes of Health Clinical Center (CC) · Sites in United States
Ages 5–25
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 6 Years to 10 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
372 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 36 · Phase 2 31 · Phase 3 18 · Phase 4 7
First in 1987; this study’s year is marked. 20 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is above the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 25 across the 296 interventional studies, 61 across the 71 observational. Of the 226 that completed or were terminated, 83 (37%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 372 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Kristie Bjornson as lead sponsor.
Kristie Bjornson has 1 study filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
24 of the studies in Cerebral Palsy with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07516067Martin PiazzaSpinal Cord Stimulation for Children With Cerebral Palsy | 2026-11 |
| NCT05339932Grand Valley State UniversityGrand Valley State University (GVSU) Skills on Wheels | 2026-11-30 |
| NCT06377085Shirley Ryan AbilityLabRepurposing 5-Azacytidine for the Treatment of Muscle Contractures in Children With Cerebral Palsy | 2026-12 |
| NCT04897347Teachers College, Columbia UniversityRobotic TruST-Postural Intervention for Children With Cerebral Palsy | 2026-12 |
| NCT03937700Shirley Ryan AbilityLabRobot Based Gait Training Therapy for Pediatric Population With Cerebral Palsy Using the CPWalker | 2026-12-01 |
Add all 24 to your calendar (.ics) → With an account.
Among the 372 studies in Cerebral Palsy with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Ambulatory children with cerebral palsy (CP) walk predominately in low intensity stride rates with little variability, thus limiting their walking activity and ability to participate in daily life. In contrast, typically developing (TD) children engage in short bursts of intense walking activity interspersed with varying intervals of low intensity walking within daily life. In order to optimize motor learning, active participation, task-specific training and multiple repetitions or massed practice is required to learn new motor skills. Short bursts of vigorous intensity locomotor treadmill training (SBLTT) alternating with low/moderate intensity was specifically designed to mimic activity patterns of TD children in a massed practice format. Pilot data suggests that SBLTT is feasible and enhances walking capacity and performance in daily life for children with CP. This project will examine the effect of SBLTT versus an equivalent dosage of traditional locomotor treadmill training (TLTT) on the primary outcomes of walking capacity and performance in children with CP and whether the effects of SBLTT on walking capacity and performance are mediated by improvements in in muscle power generation. The scientific premise is that SBLTT, that approximates the walking intensity patterns of typically developing (TD) children through a home-based massed practice protocol, will be more effective than TLTT in improving walking capacity and performance. We hypothesize that SBLTT strategies for children with CP modeled on walking patterns of TD children, will be positively mediated by muscle power generation and subsequently improve walking capacity and community walking performance and mobility. Specific aims. Aim #1. Determine the immediate and retention effects of short-burst interval LTT (SBLTT) on walking capacity in ambulatory children with CP. Aim #2. Examine the effects of treatment on community-based walking activity performance and mobility. Aim #3. Explore whether the effects of SBLTT on walking capacity and performance are mediated by muscle power generation. The proposed research will be the first step in a continuum of research that is expected to direct locomotor training protocols and rehab strategies across pediatric disabilities and positively effecting the community walking performance and mobility for children with CP.
In a randomized clinical trial, 72 ambulatory children with spastic CP (6-10 yrs.) will receive either SBLTT or an equivalent dosage of TLTT for 40 sessions, 5x/week for 8 weeks in a massed practice format. The only difference between training protocols will be the variable training (interval fast versus steady state walking speeds). Thus, the key ingredient will be the intensity of the interval training delivered in a serial blocked practice schedule. Outcomes will be collected at baseline, 4 and 8 weeks to assess dosage, and 24 weeks post training for long term retention with the primary endpoint at 8 weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
SBLTT will consist of short-bursts (30 seconds) of high speed walking alternating with 30 seconds of low/moderate speed walking. Participant will receive 40 home-based sessions (5x/week for 8 weeks) of SBLTT
Behavioral: Short Burst Interval Treadmill Training (SBLTT)
TLTT will consist of walking at steady-state speeds. Participant will receive 40 home-based sessions (5x/week for 8 weeks) of TLTT
Behavioral: Traditional Locomotor Treadmill Training (TLTT)
SBLTT will consist of short-bursts (30 seconds) of high speed walking alternating with 30 seconds of low/moderate speed walking. Total duration of walking per session will be up to 30 minutes of the 30 second alternating intervals (30sec high / 30sec low/moderate) with rests as needed. Both groups will receive 40 sessions delivered 5x/week for 8 weeks. Initial speeds for high speed walking will be 75-80% of each participant's over ground baseline fast walking speed, and low/moderate speed will be 75-80% of self-selected speed calculated from the 10-Meter Walk Test.
TLTT group will receive the same number of sessions (40) delivered 5x/week for 8 weeks with a total duration of walking per session up to 30 minutes with rests as needed. TLTT will consist of walking at steady-state speeds. Initial treadmill speed will be 75-80% of over ground self-selected walking speed. The overall goal will be to achieve 30 minutes of walking at a steady-state walking speed within each session. Speed will be increased on the next session by .1 to .4mph when the subject can walk for 30 minutes on the treadmill at the current speed with an OMNI score of \< 6/10.
Change in Walking Capacity-Self-selected Walking Speed (Normalized)
Normalized 10 Meter Walk Test in meters/second. Calculated from the 10-meter walk test in meters/second at self-selected speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.
Time frame: Baseline to 8 weeks
Change in Walking Capacity-Fast Walking Speed (Normalized)
Calculated from the 10-meter walk test in meters/second at fast walking speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.
Time frame: Baseline to 8 weeks
Change in One Minute Walk Test
Distance covered while walking as fast as possible for 1 minute measured in meters
Time frame: Baseline to 8 weeks
Change in Average Strides Per Day
Average number of strides walked per day captured by Step Watch accelerometer as worn for a minimum of 4 days.
Time frame: Baseline to 8 weeks
Absolute Change in Percent Strides/Day in Medium/High Stride Rates
StepWatch (SW) accelerometry - percent of strides/day in medium/high stride rates (\> 30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.
Time frame: Baseline to 8 weeks
Change in Right Knee Extensor Muscle Power
Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for right knee extensors at 60 degrees/second in watts.
Time frame: Baseline to 8 weeks.
Change in Left Knee Extensor Muscle Power
Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for left knee extensors at 60 degrees/second in watts.
Time frame: Baseline to 8 weeks
Change in Average Strides Per Day in the Home.
StepWatch (SW) accelerometry strides/day synchronized with Global Positioning System (GPS) home location setting- average strides per day.
Time frame: Baseline to 8 weeks
Absolute Change in Percent Average Strides/Day in the Community.
StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) home setting- percent average strides/day in the community. Calculated as percentage value at 8 weeks minus the percentage value at baseline.
Time frame: Baseline to 8 weeks
Change in PROMIS Physical Function Domain Score -
Patient-Reported Outcomes Measurement Information System (PROMIS v1.0 Parent Pediatric Profile) physical function domain score T scores, Mean of 50 and standard deviation of 10. Higher is a better report of physical function.
Time frame: Baseline to 8 weeks
Change in Gait Outcomes Assessment List (GOAL) Total Score
Parent report Gait Outcome Assessment List (GOAL).total score scale 0-10 with higher score better parent report of gait walking skills and mobility.
Time frame: Baseline to 8 weeks
Change in Right Knee Peak Extensor Muscle Torque (Normalized).
Isokinetic Peak Torque for right knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.
Time frame: Baseline to 8 weeks.
Absolute Change in Percent Average Strides/Day in Medium/High Activity in the Home.
StepWatch (SW) accelerometry synchronized (average strides/day) with Global Positioning System (GPS) home setting- percent average strides/day in medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.
Time frame: Baseline to 8 weeks
Absolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the Community
StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) community setting- percent average strides/day at medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.
Time frame: Baseline to 8 weeks
Change in Left Knee Peak Extensor Muscle Torque (Normalized).
Isokinetic Peak Torque for Left knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.
Time frame: Baseline to 8 weeks
| Milestone | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Started | 28 | 32 |
| Completed | 24 | 29 |
| Not completed | 4 | 3 |
Normalized 10 Meter Walk Test in meters/second. Calculated from the 10-meter walk test in meters/second at self-selected speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.
| Unitless | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Walking Capacity-Self-selected Walking Speed (Normalized) | 0.03 ± 0.05 | 0.01 ± 0.04 |
Calculated from the 10-meter walk test in meters/second at fast walking speed and then normalized by the following formula: velocity / square root (9.81 x leg length) yielding non-dimensional units. Higher values represent faster gait speeds.
| Unitless | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Walking Capacity-Fast Walking Speed (Normalized) | 0.04 ± 0.07 | 0.02 ± 0.04 |
Distance covered while walking as fast as possible for 1 minute measured in meters
| Distance in Meters | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in One Minute Walk Test | 7.95 ± 16.45 | 7.9 ± 10.97 |
Average number of strides walked per day captured by Step Watch accelerometer as worn for a minimum of 4 days.
| Average strides per day | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Average Strides Per Day | -168.65 ± 1855.71 | -143.85 ± 1389.55 |
StepWatch (SW) accelerometry - percent of strides/day in medium/high stride rates (\> 30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.
| Absolute change in percent | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Absolute Change in Percent Strides/Day in Medium/High Stride Rates | -0.24 ± 9.21 | -0.55 ± 10.48 |
Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for right knee extensors at 60 degrees/second in watts.
| Watts | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Right Knee Extensor Muscle Power | -0.07 ± 0.17 | 0.01 ± 0.13 |
StepWatch (SW) accelerometry strides/day synchronized with Global Positioning System (GPS) home location setting- average strides per day.
| Strides/day in Home location | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Average Strides Per Day in the Home. | -133.45 ± 1289.88 | -245.96 ± 897.9 |
StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) home setting- percent average strides/day in the community. Calculated as percentage value at 8 weeks minus the percentage value at baseline.
| Absolute percent change | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Absolute Change in Percent Average Strides/Day in the Community. | -591.07 ± 760.98 | 202.71 ± 1029.43 |
Patient-Reported Outcomes Measurement Information System (PROMIS v1.0 Parent Pediatric Profile) physical function domain score T scores, Mean of 50 and standard deviation of 10. Higher is a better report of physical function.
| standard score | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in PROMIS Physical Function Domain Score - | 3.15 ± 4.33 | 2.03 ± 2.7 |
Parent report Gait Outcome Assessment List (GOAL).total score scale 0-10 with higher score better parent report of gait walking skills and mobility.
| GOAL total standard score | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Gait Outcomes Assessment List (GOAL) Total Score | 8.89 ± 9.48 | 5.11 ± 8.08 |
Isokinetic Peak Torque for right knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.
| Newton Meters/kg | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Right Knee Peak Extensor Muscle Torque (Normalized). | -0.18 ± 0.32 | -0.08 ± 0.26 |
StepWatch (SW) accelerometry synchronized (average strides/day) with Global Positioning System (GPS) home setting- percent average strides/day in medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.
| absolute change in percent | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Absolute Change in Percent Average Strides/Day in Medium/High Activity in the Home. | 0 ± 0.12 | 0 ± 0.07 |
StepWatch (SW) accelerometry synchronized with Global Positioning System (GPS) community setting- percent average strides/day at medium/high stride rates (\>30 strides/minute). Calculated as percentage value at 8 weeks minus the percentage value at baseline.
| absolute change in percent | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Absolute Change in Percent Average Strides/Day at Medium/High Stride Rates in the Community | -0.02 ± 0.13 | 0.04 ± 0.14 |
Isokinetic dynamometer (Biodex System 3/4) according to published standard procedures for isokinetic power. Calculated for left knee extensors at 60 degrees/second in watts.
| Watts | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Left Knee Extensor Muscle Power | 0.01 ± 0.17 | -0.01 ± 0.11 |
Isokinetic Peak Torque for Left knee extensors at 60 deg/s as measured by Biodex normalized by kg/weight.
| Newton Meters/kg | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| Change in Left Knee Peak Extensor Muscle Torque (Normalized). | -0.01 ± 0.32 | 0 ± 0.21 |
Collected over From baseline until end of follow-up, up to training session, up to 28 weeks. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Short Burst Interval Treadmill Training (SBLTT) | 0/28 (0%) | 2/28 (7.1%) | 16/28 (57.1%) |
| Traditional Locomotor Treadmill Training (TLTT) | 0/32 (0%) | 0/32 (0%) | 16/32 (50%) |
| Event | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| diabetes onset (not related to the study)Endocrine disorders | 1/28 | 0/32 |
| tonsil surgery (not related to the study)Surgical and medical procedures | 1/28 | 0/32 |
| Event | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) |
|---|---|---|
| foot painMusculoskeletal and connective tissue disorders | 1/28 | 5/32 |
| Influenza-like illnessGeneral disorders | 0/28 | 4/32 |
| broken orthoticProduct Issues | 3/28 | 0/32 |
| nausea/vomitingGastrointestinal disorders | 3/28 | 2/32 |
| COVID-19-related eventGeneral disorders | 3/28 | 2/32 |
| skin blisterSkin and subcutaneous tissue disorders | 3/28 | 3/32 |
| knee painMusculoskeletal and connective tissue disorders | 1/28 | 3/32 |
| Seizure-like activityNervous system disorders | 2/28 | 1/32 |
| headacheNervous system disorders | 0/28 | 2/32 |
| muscle cramp/soreness/spasmMusculoskeletal and connective tissue disorders | 1/28 | 2/32 |
| Age, Continuous(Years) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| Mean | 8.26 ± 1.70 | 8.48 ± 1.46 | 8.34 ± 1.58 |
| Age, Customized(Participants) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| 6.0 to 8.4 years | 17 | 16 | 33 |
| 8.5 to 11 years | 11 | 16 | 27 |
| Sex: Female, Male(Participants) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| Female | 8 | 15 | 23 |
| Male | 20 | 17 | 37 |
| Race (NIH/OMB)(Participants) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| American Indian or Alaska Native | 1 | 0 | 1 |
| Asian | 3 | 1 | 4 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 3 | 4 | 7 |
| White | 15 | 18 | 33 |
| More than one race | 4 | 8 | 12 |
| Unknown or Not Reported | 2 | 1 | 3 |
| Ethnicity (NIH/OMB)(Participants) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| Hispanic or Latino | 4 | 3 | 7 |
| Not Hispanic or Latino | 24 | 29 | 53 |
| Unknown or Not Reported | 0 | 0 | 0 |
| Region of Enrollment(participants) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| United States | 28 | 32 | 60 |
| Gross Motor Function Classification System (GMFCS)(Participants) | Short Burst Interval Treadmill Training (SBLTT) | Traditional Locomotor Treadmill Training (TLTT) | Total |
|---|---|---|---|
| GMFCS Level I | 4 | 6 | 10 |
| GMFCS Level II | 20 | 22 | 42 |
| GMFCS Level III | 4 | 4 | 8 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2019 to primary completion in Aug 2025, 68 months.
Results were first posted in Oct 2026, 1 year 2 months after primary completion.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 68 months is above that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 29, 2026: primary completion Jun 2025 → Aug 2025 and completion Aug 2025 → Aug 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.